Autoreactive T-cell responses to myeloperoxidase in patients with antineutrophil cytoplasmic antibody-associated vasculitis and in healthy individuals

References

• Csernok E. Anti-neutrophil cytoplasmic antibodies and patho-genesis of small vessel vasculitides. Autoimmun Rev. 2003;2:158–64.
   PubMed Web of Science ®Google Scholar
• Seo P, Stone JH. The antineutrophil cytoplasmic antibody-asso-ciated vasculitides. Am J Med. 2004;117:39–50.
   PubMed Web of Science ®Google Scholar
• Rarok AA, Limburg PC, Kallenberg CG. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol. 2003;74:3–15.
   Google Scholar
• Weidner S, Neupert W, Goppelt-Struebe M, Rupprecht HD. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum. 2001;44:1698–706.
   Google Scholar
• Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol. 1992;141: 335–42.
   Google Scholar
• Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, et al. Predominance of IgG1 and IgG4 sub-classes of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol. 1991;83:379–86.
   Google Scholar
• Tsuchiya N, Kobayashi S, Kawasaki A, Kyogoku C, Arimura Y, Yoshida M, et al. Genetic background of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: asso-ciation of HLA-DRB1*0901 with microscopic polyangiitis. J Rheumatol. 2003;30:1534–40.
   PubMed Web of Science ®Google Scholar
• Mathieson PW, Cobbold SP, Hale G, Clark MR, Oliveira DB, Lockwood CM, et al. Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med. 1990;323:250–4.
   PubMed Web of Science ®Google Scholar
• Lockwood CM, Thiru S, Isaacs JD, Hale G, Waldmann H. Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy. Lancet 1993;341:1620–2.
   Google Scholar
• Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, et al. Antineutrophil cytoplasmic autoantibodies specific for myelo-peroxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest. 2002;110:955–63.
   PubMed Web of Science ®Google Scholar
• Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37: 187–92.
   PubMed Web of Science ®Google Scholar
• Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in sys-temic necrotizing vasculitis. Q J Med. 1994;87:671–8.
   Google Scholar
• Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JWC, Dadoniene J, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoanti-bodies 2003;349:36–44.
   Google Scholar
• Inoko H, Ota M. PCR-RFLP. In: Hui KM, Bidwill JL, editors. Handbook of HLA typing techniques. Boca Raton: CRC Press; 1993. p. 9–70.
   Google Scholar
• Kuwana M, Medsger TA Jr, Wright TM. Detection of anti-DNA topoisomerase I antibody by an enzyme-linked immunosorbent assay using overlapping recombinant polypeptides. Clin Immunol Immunopathol. 1995;76:266–78.
   PubMedGoogle Scholar
• Maim CV, Riggs PD, Grandea AGIII, Slatko BE, Moran LS, Taquliamonte JA, et al. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein. Gene 1988;74:365–73.
   PubMedGoogle Scholar
• Kuwana M, Medsger TA Jr, Wright TM. T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors. J Clin Invest. 1995;96: 586–96.
   PubMedGoogle Scholar
• Hattori N, Kuwana M, Kaburaki J, Mimori T, Ikeda Y, Kawa-kami Y. T cells that are autoreactive to /32-glycoprotein I in patients with antiphospholipid syndrome and healthy individuals. Arthritis Rheum. 2000;43: 65–75.
   Google Scholar
• Kuwana M, Kaburaki J, Ikeda Y. Autoreactive T cells to platelet GPIIb-IIIa in immune thrombocytopenic purpura. Role in pro-duction of anti-platelet autoantibody. J Clin Invest. 1998;102: 1393–402.
   Google Scholar
• Griffith ME, Coulthart A, Pusey CD. T cell responses to mye-loperoxidase (MPO) and proteinase 3 (PR3) in patients with systemic vasculitis. Clin Exp Immunol. 1996;103: 253–8.
   Google Scholar
• Yoshida M, Iwahori T, Nakabayashi I, Akashi M, Watanabe T, Yoshikawa N. In vitro production of myeloperoxidase anti-neu-trophil cytoplasmic antibody and establishment of Th 1-type T cell lines from peripheral blood lymphocytes of patients. Clin Exp Rheumatol. 2005;23:227–30.
   PubMedGoogle Scholar
• Pember SO, Shapira R, Kinkada JM Jr. Multiple forms of mye-loperoxidase from human neutrophilic granulocytes: evidence for differences in compartmentalization, enzymatic activity, and subunit structure. Arch Biochem Biophys. 1993;221:391–403.
   Google Scholar
• Kuwana M, Ikeda Y. The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J. Hematol. 2005;81:106–12.
   PubMed Web of Science ®Google Scholar
• Kuwana M. /32-glycoprotein I: antiphospholipid syndrome and T-cell reactivity. Thromb Res. 2004;114:347–55.
   PubMedGoogle Scholar
• King WJ, Brooks CJ, Holder R, Hughes P, Adu D, Savage CO. T lymphocyte responses to anti-neutrophil cytoplasmic autoantibody (ANCA) antigens are present in patients with ANCA-associated systemic vasculitis and persist during disease remission. Clin Exp Immunol. 1998;112:539–46.
   PubMedGoogle Scholar
• Brouwer E, Stegeman CA, Huitema MG, Limburg PC, Kallen-berg CG. T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG). Clin Exp Immu-nol. 1994;98: 448–53.
   Google Scholar
• Lanzavecchia A. How can cryptic epitopes trigger autoimmunity? J Exp Med. 1995;181:1945–8.
   Google Scholar
• Kuwana M, Kaburaki J, Kitasato H, Kato M, Kawai S, Kawakami Y, et al. Immunodominant epitopes on glycoprotein llb-IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood 2001;98:130–9.
   PubMed Web of Science ®Google Scholar
• Eguchi K. Apoptosis in autoimmune diseases. Intern Med. 2001;40:275–84.
   PubMed Web of Science ®Google Scholar
• Zipp F. Apoptosis in multiple sclerosis. Cell Tissue Res. 2000;301:163–71.
   PubMedGoogle Scholar
• Ito Y, Nieda M, Uchigata Y, Nishimura M, Tokunaga K, Kuwata S, et al. Recognition of human insulin in the context of HLA-DRB1*0406 products by T cells of insulin autoimmune syndrome patients and healthy donors. J Immunol. 1993;151:5770–6.
   PubMed Web of Science ®Google Scholar